`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Paper No. ____
`Filed: July 25, 2017
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`__________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`__________________
`
`IBG LLC,
`INTERACTIVE BROKERS LLC,
`TRADESTATION GROUP, INC., and
`TRADESTATION SECURITIES, INC.
`
`Petitioners
`
`v.
`
` TRADING TECHNOLOGIES INTERNATIONAL, INC.
`
`Patent Owner
`_________________
`
`Case CBM2016-00087
`U.S. Patent 7,412,416 B2
`_________________
`
`PATENT OWNER’S REPLY IN SUPPORT OF ITS
`MOTION TO EXCLUDE
`
`
`
`
`
`
`Case CBM2016-00087
`U.S. Patent 7,412,416 B2
`
`
`TABLE OF CONTENTS
`
`I.
`
`TSE IS IRRELEVANT ................................................................................... 1
`
`II. KAWASHIMA IS HEARSAY ....................................................................... 2
`
`III. TSE HAS NOT BEEN AUTHENTICATED .................................................. 3
`
`IV. THE THOMAS TESTIMONY SHOULD BE EXCLUDED ......................... 4
`
`
`
`
`
`
`
`
`
`i
`
`
`
`Case CBM2016-00087
`U.S. Patent 7,412,416 B2
`
`
`I.
`
`TSE IS IRRELEVANT
`
`TSE is not relevant to any issue remaining in these proceedings. Petitioners
`
`argue that TSE is relevant to “factual issues undergirding the § 101 analysis and
`
`the CBM-eligibility analysis.” Opp. at 2. But belying this is Petitioners’ failure to
`
`set forth any analysis of how TSE demonstrates any of these factual issues.
`
`Indeed, Petitioners mention TSE just twice in the patent-eligibility section of their
`
`Petition: both times as mere “see” cites to one-sentence arguments regarding
`
`dependent claims 13, 23, and 24 with no further explanation of relevance. Pet. at
`
`34-35. Petitioners fail to discuss (or cite) TSE in connection with a CBM-
`
`eligibility analysis. And Petitioners fail to even cite TSE in their Reply.
`
`Two parenthetical cites with no explanation of relevance does not
`
`demonstrate that TSE is probative on any fact remaining in this proceeding. Thus,
`
`TSE should be excluded. Apple Inc. v. Smartflash LLC, CBM2014-00106, Paper
`
`52, p. 25 (PTAB Sep. 25, 2015) (excluding evidence not relied upon). Allowing
`
`Petitioners to rely on TSE for these arguments, which are apparently being made
`
`for the first time in an opposition to a motion to exclude, violates the APA and
`
`Patent Owner’s Due Process rights because it prevents Patent Owner from
`
`meaningfully responding. Dell Inc. v. Acceleron, LLC, 818 F.3d 1293, 1301 (Fed.
`
`Cir. 2016).
`
`1
`
`
`
`Case CBM2016-00087
`U.S. Patent 7,412,416 B2
`
`
`II. KAWASHIMA IS HEARSAY
`
`Petitioners argue that TT conceded that the Kawashima deposition transcript
`
`was admissible. But TT did not concede that the 2005 Kawashima deposition
`
`transcript was admissible, and TT did not concede that the deposition transcript
`
`authenticates Exhibit 1015 (“TSE”). E.g., CBM2016-00179, Paper 114. Rather, in
`
`other CBM proceedings, TT set forth an alternative argument that applied for that
`
`CBM proceeding: the deposition transcript and TT’s evidence from district court
`
`litigation should stand or fall together based on mutual hearsay objections. Id. at 6
`
`(“[t]o the extent the Board excludes any of Patent Owner’s evidence from district
`
`court litigation, which it should not, the Board should likewise exclude the 2005
`
`Kawashima transcript.”).
`
`Notably, Petitioners do not dispute that they could have obtained more
`
`probative evidence from Kawashima. As explained in TT’s motion, Petitioners
`
`could have obtained a declaration from Kawashima during the time they privately
`
`met with him prior to his 2016 deposition. They also could have elicited testimony
`
`at his deposition addressing the deficiencies of the 2005 Kawashima testimony.
`
`They did not. As such, the 2005 Kawashima transcript is not more probative than
`
`other evidence they could have obtained through reasonable efforts. See FRE
`
`807(a)(2). The 2005 Kawashima transcript thus does not qualify for the residual
`
`hearsay exception and should be excluded as hearsay.
`
`2
`
`
`
`Case CBM2016-00087
`U.S. Patent 7,412,416 B2
`
`
`III. TSE HAS NOT BEEN AUTHENTICATED
`
`Even if the Kawashima deposition transcript is admitted, it does not
`
`authenticate TSE. Indeed, this transcript is insufficient to establish that Exhibit
`
`1015 is the same document allegedly distributed in 1998 by the Tokyo Stock
`
`Exchange. See Pet. at 18-19, 37. As explained in TT’s motion, the 2005
`
`Kawashima transcript raises more doubt that it resolves. Mot. at 3-4. Specifically,
`
`TT highlighted portions of Kawashima that demonstrate that Kawashima was
`
`unable to authenticate TSE in a way that establishes that the TSE manual was the
`
`same document allegedly distributed in 1998 by the Tokyo Stock Exchange. Id.
`
`(citing Ex. 1018, pp. 97-99).
`
`Further, whether or not TSE is a business record or appears to be an
`
`authentic TSE document, nothing establishes that it is the “prior art” document to
`
`which Petitioners cite. Specifically, Petitioners argue that the document is
`
`authenticated under FRE 901(b)(4) because it has a distinctive layout and has
`
`illustrations as well as Bates numbering. Opp. at 5-6. But such characteristics of
`
`the purported TSE document do nothing to establish that the document is the same
`
`manual allegedly distributed by the Tokyo Stock Exchange in 1998. See Pet. at
`
`18-19. Indeed, these characteristics do nothing to establish that the document was
`
`publicly available such that it demonstrates what was well-known or conventional
`
`in the art at the time. Rather, these characteristics, at best, show that the purported
`
`3
`
`
`
`Case CBM2016-00087
`U.S. Patent 7,412,416 B2
`
`
`“prior art” TSE document is the same (or similar) TSE document other defendants
`
`have used in other related litigations. As such, it is not self-authenticated in any
`
`way that can establish it is prior art, or evidence of what was “well-known” or
`
`“conventional” at the time, in this proceeding.
`
`The 2016 deposition transcript does not corroborate the 2005 testimony.
`
`The portions cited by Petitioners do not establish that the TSE manual prepared by
`
`Kawashima was the same manual allegedly disseminated in 1998. Ex. 1043 at 45-
`
`61. These portions still suggest that Mr. Kawashima could not have examined the
`
`document in a way that would have differentiated it from any other version. Id.
`
`As explained in TT’s motion, the 2016 deposition transcript also proves Mr.
`
`Kawashima’s bias. Petitioners argue that any doubts go to the weight of the
`
`testimony, not to its admissibility. Opp. at 9. TT agrees. Mr. Kawashima’s bias
`
`goes to the weight that his testimony should be given. Mr. Kawashima’s testimony
`
`should be given no weight, so it cannot authenticate TSE.
`
`IV. THE THOMAS TESTIMONY SHOULD BE EXCLUDED
`
`Petitioners do not dispute that Mr. Thomas’ testimony was given in response
`
`to vague and ambiguous questions. And Petitioners do not dispute that they are
`
`using this testimony in a confusing and misleading manner to argue that Mr.
`
`Thomas testified that the claimed inventions do not improve computers. Opp. at 1-
`
`2 (asserting that “Mr. Thomas, admitted that certain claims of a related patent do
`
`4
`
`
`
`Case CBM2016-00087
`U.S. Patent 7,412,416 B2
`
`not improve computers. (See, e.g., Ex. 1060 at 248, 263-69.)”). Instead, Petitioners
`
`defer to the Board’s ability to accord the evidence “appropriate weight.” Id. at 12.
`
`But the Board’s ability to accord evidence “appropriate weight” does not entitle
`
`Petitioners to rely on testimony elicited by vague and ambiguous questions. Thus,
`
`the Board should exclude the evidence.
`
`Petitioners also claim that because Mr. Thomas answered the questions at
`
`all, the testimony should not be excluded. Id. at 13. But the fact that the witness is
`
`entitled to seek clarification does not cure an objectionable question. See Office
`
`Patent Trial Practice Guide, 77 Fed. Reg. 48,756, 48,772 (Aug. 14, 2012) (“An
`
`objection at the time of the examination—whether to evidence, to a party’s
`
`conduct, to the officer’s qualifications, to the manner of taking the testimony, or
`
`any aspect of the testimony—must be noted on the record, but the examination still
`
`proceeds; testimony is taken subject to any such objection.”). Patent Owner timely
`
`objected to objectionable questioning. Ex. 1060 at 248, 263-269. Mr. Thomas’
`
`answers do not obviate these objections and do not moot Patent Owner’s motion.
`
`Indeed, Mr. Thomas did not admit that the claimed inventions do not
`
`improve computers. Mr. Thomas simply stated what was not explicitly recited by
`
`the claims. The probative value of this testimony is substantially outweighed by a
`
`danger of unfair prejudice and confusing the issues as the result of vague
`
`questioning. Accordingly, it should be excluded under FRE 403.
`
`5
`
`
`
`
`
`
`
`Date: July 25, 2017
`
`Case CBM2016-00087
`U.S. Patent 7,412,416 B2
`
`
`Respectfully submitted,
`
`MCDONNELL BOEHNEN HULBERT &
`BERGHOFF LLP
`
`/Jennifer M. Kurcz/
`
`Jennifer M. Kurcz,
`Back-Up Counsel, Reg. No. 54,481
`
`Counsel for Patent Owner
`
`300 South Wacker Drive
`Chicago, Illinois 60606
`(312) 913-0001
`
`
`6
`
`
`
`Case CBM2016-00087
`U.S. Patent 7,412,416 B2
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing Patent
`
`Owner’s Reply in Support of its Motion to Exclude was served on July 25,
`
`2017, via email directed to counsel of record for the Petitioner at the following:
`
`Robert E. Sokohl
`rsokohl-PTAB@skgf.com
`
`Lori A. Gordon
`lgordon-PTAB@skgf.com
`
`Richard M. Bemben
`rbemben-PTAB@skgf.com
`
`John C. Phillips
`PTABINBOUND@fr.com
`
`PTAB@skgf.com
`
`
`
`
`
`
`Date: July 25, 2017
`
`
`
`
`
`
`
`/Cole B. Richter/
`
`
`
`
`
`
`
`
`
`7
`
`